Analyst Research

Report Title Price
Provider: GlobalData
Provider: Finlabo SIM Spa
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bayer AG Completes Acquisition Of Steigerwald Arzneimittelwerk GmbH

Monday, 1 Jul 2013 06:44am EDT 

Bayer AG announced that it has completed the acquisition of Steigerwald Arzneimittelwerk GmbH (Steigerwald). The transaction was cleared by the relevant antitrust authorities. Bayer AG announced the signing of an agreement to acquire the family-owned business in May 2013. The company employs approximately 180 people and has its headquarters and manufacturing site in Darmstadt. Bayer AG has committed to take over all of Steigerwald’s employees. The Darmstadt site and the sales organization are to retain their existing structures. It was agreed not to disclose the purchase price. 

Company Quote

-0.2 -0.17%
23 Dec 2014